Cargando…

Safety and Immunogenicity of a Shigella Bivalent Conjugate Vaccine (ZF0901) in 3-Month- to 5-Year-Old Children in China

No licensed Shigella vaccine is presently available globally. A double-blinded, randomized, placebo-controlled, age descending phase II clinical trial of a bivalent conjugate vaccine was studied in China. The vaccine ZF0901 consisted of O-specific polysaccharides purified and detoxified from lipopol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mo, Yi, Fang, Wenjian, Li, Hong, Chen, Junji, Hu, Xiaohua, Wang, Bin, Feng, Zhengli, Shi, Honghua, He, Ying, Huang, Dong, Mo, Zhaojun, Ye, Qiang, Du, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780113/ https://www.ncbi.nlm.nih.gov/pubmed/35062694 http://dx.doi.org/10.3390/vaccines10010033

Ejemplares similares

A bivalent vaccine confers immunogenicity and protection against Shigella flexneri and enterotoxigenic Escherichia coli infections in mice
por: Medeiros, Pedro Henrique Q. S., et al.
Publicado: (2020)

Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine
por: Cao, Yunlong, et al.
Publicado: (2021)

Logsets and ZF Theory
por: Nambiar, K K
Publicado: (2002)

Preclinical Toxicity and Immunogenicity of a COVID-19 Vaccine (ZF2001) in Cynomolgus Monkeys
por: Yang, Hongzhong, et al.
Publicado: (2022)

Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females
por: Shi, Li-Wei, et al.
Publicado: (2023)

Safety, Tolerability, and Immunogenicity of COVID-19 Bivalent Vaccination
por: Saxena, Divyasha, et al.
Publicado: (2023)

Bivalent Conjugate Vaccine Induces Dual Immunogenic Response That Attenuates Heroin and Fentanyl Effects in Mice
por: Barrientos, Rodell C., et al.
Publicado: (2021)

Models of ZF-set theory
por: Felgner, Ulrich
Publicado: (1971)

Formalization of Forcing in Isabelle/ZF
por: Gunther, Emmanuel, et al.
Publicado: (2020)

Effects of Lactobacillus acidophilus KLDS1.0901 on Proliferation and Apoptosis of Colon Cancer Cells
por: Yue, Yingxue, et al.
Publicado: (2022)

ZF-a tool for electroweak fits
por: Quast, G
Publicado: (1996)

OA09.01. Massage therapy for osteoarthritis of the knee: a randomized dose-finding trial
por: Perlman, A, et al.
Publicado: (2012)

Draft Genome Sequence of the First South Korean Clinical Isolate of Burkholderia pseudomallei, H0901
por: Shin, Yong-Woo, et al.
Publicado: (2018)

IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway
por: Liu, Dong, et al.
Publicado: (2019)

Bivalent EGFR-Targeting DARPin-MMAE Conjugates
por: Karsten, Lennard, et al.
Publicado: (2022)

Safety and immunogenicity of heterologous recombinant protein subunit vaccine (ZF2001) booster against COVID-19 at 3–9-month intervals following two-dose inactivated vaccine (CoronaVac)
por: Liao, Yuting, et al.
Publicado: (2022)

Superior Neuroprotective Efficacy of LAU-0901, a Novel Platelet-Activating Factor Antagonist, in Experimental Stroke
por: Belayev, Ludmila, et al.
Publicado: (2011)

NH(2)‐terminal fragment of ZF21 protein suppresses tumor invasion via inhibiting the interaction of ZF21 with FAK
por: Nagano, Makoto, et al.
Publicado: (2020)

Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters
por: Collier, Ai-ris Y., et al.
Publicado: (2023)

Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters
por: Collier, Ai-ris Y., et al.
Publicado: (2022)

Complete Genome Sequence of a Virulent Strain, Streptococcus iniae ISET0901, Isolated from Diseased Tilapia
por: Pridgeon, Julia W., et al.
Publicado: (2014)

Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men
por: Hannawi, Suad, et al.
Publicado: (2023)

Evaluation of a Rapid Immunochromatographic ODK-0901 Test for Detection of Pneumococcal Antigen in Middle Ear Fluids and Nasopharyngeal Secretions
por: Hotomi, Muneki, et al.
Publicado: (2012)

Safety and immunogenicity of inactivated COVID-19 vaccine CoronaVac and the RBD-dimer–based COVID-19 vaccine ZF2001 in chronic hepatitis B patients
por: Wu, Shiheng, et al.
Publicado: (2023)

Conjugation in Tetrahymena pyriformis. The effect of polylysine, concanavalin A, and bivalent metals on the conjugation process
Publicado: (1976)

The identification of novel immunogenic antigens as potential Shigella vaccine components
por: de Alwis, Ruklanthi, et al.
Publicado: (2021)

Comparison of the safety and persistence of immunogenicity of bivalent HPV16/18 vaccine in healthy 9–14-year-old and 18–26-year-old Chinese females: A randomized, double-blind, non-inferiority clinical trial
por: Li, Juan, et al.
Publicado: (2023)

Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China
por: Mo, Zhaojun, et al.
Publicado: (2017)

Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults
por: Dai, Lianpan, et al.
Publicado: (2022)

Assessing the in vivo ameliorative effects of Lactobacillus acidophilus KLDS1.0901 for induced non-alcoholic fatty liver disease treatment
por: Wang, Yanbo, et al.
Publicado: (2023)

Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines
por: Capeding, Maria Rosario Z., et al.
Publicado: (2017)

LB750. Safety and Immunogenicity of a Bivalent Omicron-Containing Booster Vaccine against COVID-19
por: Chalkias, Spyros, et al.
Publicado: (2022)

Immunogenicity of a Bivalent Non-Purified Recombinant Vaccine against Botulism in Cattle
por: Moreira, Clóvis, et al.
Publicado: (2018)

Immunogenicity of Bivalent Omicron BA.4/5–Adapted Vaccine in Hemodialysis Patients
por: Anft, Moritz, et al.
Publicado: (2023)

Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol
por: Tan, Ngoc H., et al.
Publicado: (2022)

Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study
por: Capeding, Maria Rosario, et al.
Publicado: (2020)

Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex
por: Turbyfill, K. Ross, et al.
Publicado: (2018)

Immunogenic evaluation of chimeric recombinant protein against ETEC, EHEC and Shigella
por: Khalouie, Farzane, et al.
Publicado: (2017)

Safety and immunogenicity of two doses of quadrivalent meningococcal conjugate vaccine or one dose of meningococcal group C conjugate vaccine, both administered concomitantly with routine immunization to 12- to 18-month-old children
por: Noya, Francisco, et al.
Publicado: (2014)

The Phosphoinositide-Binding Protein ZF21 Regulates ECM Degradation by Invadopodia
por: Hoshino, Daisuke, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_p97n43r1m7o1h75a3hqaqct2kc